Transcend Capital Advisors, LLC Gsk PLC Transaction History

Transcend Capital Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$42.05 - $47.77 $22,538 - $25,604	-536 Reduced 9.17%	5,312 $231,000
Q1 2022 Apr 20, 2022	BUY	$40.23 - $47.74 $14,885 - $17,663	370 Added 6.75%	5,848 $255,000
Q4 2021 Jan 20, 2022	SELL	$38.88 - $45.31 $48,988 - $57,090	-1,260 Reduced 18.7%	5,478 $242,000
Q3 2021 Nov 04, 2021	SELL	$38.79 - $43.16 $40,496 - $45,059	-1,044 Reduced 13.42%	6,738 $271,000
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $3,359 - $3,814	-92 Reduced 1.17%	7,782 $311,000
Q1 2021 May 12, 2021	BUY	$34.27 - $40.01 $205 - $240	6 Added 0.08%	7,874 $280,000
Q4 2020 Feb 12, 2021	SELL	$34.07 - $39.94 $48,072 - $56,355	-1,411 Reduced 15.21%	7,868 $290,000
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $353,622 - $398,904	9,279 New	9,279 $349,000
Q2 2020 Aug 05, 2020	SELL	$37.87 - $43.58 $352,077 - $405,163	-9,297 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$32.47 - $48.83 $9,611 - $14,453	-296 Reduced 3.09%	9,297 $352,000
Q4 2019 Feb 19, 2020	BUY	$42.0 - $48.25 $402,906 - $462,862	9,593 New	9,593 $451,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Transcend Capital Advisors, LLC with notifications on news.